APEX1 and hepatocellular carcinoma: Additionally, APE1 was considered to be a biomarker for cancer detection, and it was demonstrated that APE1 was often characteristically overexpressed in a variety of cancer cells such as hepatocellular carcinoma cells and lung cancer cells [142,143,144,145].